IMMPACT BIO USA INC.

Profile

Company Names

IMMPACT BIO USA INC.

Addresses

8501 FALLBROOK AVENUE, SUITE 200, WEST HILLS, CA 91304

4010 ADOLFO ROAD, SUITE A, CAMARILLO, CA 93012

4010 ADOLFO ROAD, SUITE A, CAMARILLO, CA 93012

Phone Numbers

805-437-9706

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$143,605,923.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-01-14 
$139,855,923.00 
$141,755,472.00 
$1,899,549.00 
Equity 
1
2020-07-16 
$3,750,000.00 
$5,500,000.00 
$1,750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
YVONNE 
YU-HSUAN 
CHEN 
DIRECTOR
IMMPACT BIO USA INC.
EREZ 
 
CHIMOVITS 
DIRECTOR
ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  ADICET BIO, INC.   |  LOGICBIO THERAPEUTICS, INC.   |  ATOX BIO INC.   |  NOVUS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  IMMPACT BIO USA INC.   |  GALECTO, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.
XIANGMIN 
 
CUI 
DIRECTOR
GENEWEAVE BIOSCIENCES, INC.   |  DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND I, L.P.   |  GENAPSYS, INC.   |  LEVITAS, INC.   |  DECHENG CAPITAL GLOBAL HEALTHCARE FUND, LP   |  DECHENG CAPITAL GLOBAL HEALTHCARE FUND (OFFSHORE), LP   |  IMMPACT BIO USA INC.   |  SUNNYBAY BIOTECH, INC.   |  DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V, L.P.   |  DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V-A, L.P.   |  DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V-B, L.P.
SHEILA 
 
GUIRATHI 
DIRECTOR
IMMPACT BIO USA INC.
RICHARD 
 
KENDALL 
EXECUTIVE OFFICER, DIRECTOR
ENTEGRION INC   |  BEEKEN BIOMEDICAL, LLC   |  IMMPACT BIO USA INC.
ASSAF 
 
KERET 
DIRECTOR
RMGP BIO-PHARMA INVESTMENT FUND, L.P.   |  IMMPACT BIO USA INC.
HAN 
 
LEE 
EXECUTIVE OFFICER
NOTESFIRST, INC.   |  ARCELLX, INC.   |  ARBOR PACIFIC INC.   |  IMMPACT BIO USA INC.
ANAT 
 
NURSELLA 
EXECUTIVE OFFICER
IMMPACT BIO USA INC.   |  EXSILIO THERAPEUTICS INC.   |  AVERNA THERAPEUTICS INC.
SUMANT 
 
RAMACHANDRA 
EXECUTIVE OFFICER, DIRECTOR
IMMPACT BIO USA INC.
MICHAL 
 
SILVERBERG 
DIRECTOR
GALERA THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ADICET BIO, INC.   |  IMMPACT BIO USA INC.   |  REDONA THERAPEUTICS, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.   |  AVERNA THERAPEUTICS INC.
ROBBIE 
 
WOODMAN 
DIRECTOR
IMMPACT BIO USA INC.
ASISH 
 
XAVIER 
DIRECTOR
CELLADON CORP   |  AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  ISCIENCE INTERVENTIONAL CORP   |  ISCIENCE INTERVENTIONAL CORP   |  CATALYST BIOSCIENCES INC   |  GENOCEA BIOSCIENCES, INC.   |  ALDEXA THERAPEUTICS, INC.   |  E-SCAPE BIO, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VIACYTE INC.   |  ADICET BIO, INC.   |  ESCAPE BIO, INC.   |  IMMPACT BIO USA INC.   |  PAIGE.AI, INC.   |  SONOTHERA, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
CINDY 
 
XIONG 
DIRECTOR
IMMPACT BIO USA INC.   |  SLATE MEDICINES, INC.
YVONNE 
 
YAMANAKA 
DIRECTOR
ARTIVA BIOTHERAPEUTICS, INC.   |  IMMPACT BIO USA INC.   |  EYCONIS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
DAVID 
 
ZIGDON 
DIRECTOR
IMMPACT BIO USA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-14 
2022-01-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-14 
2020-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#